These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Convenient Synthesis of Novel Isoxazolidine and Isoxazole Isoquinolinones Fused Hybrids. Ouzounthanasis KA; Rizos SR; Koumbis AE Molecules; 2023 Dec; 29(1):. PubMed ID: 38202674 [TBL] [Abstract][Full Text] [Related]
4. SynBio-SynChem Approaches to Diversifying the Pacidamycins through the Exploitation of an Observed Pictet-Spengler Reaction. Cartmell C; Abou Fayad A; Lynch R; Sharma SV; Hauck N; Gust B; Goss RJM Chembiochem; 2021 Feb; 22(4):712-716. PubMed ID: 33058439 [TBL] [Abstract][Full Text] [Related]
5. Design of novel water-soluble isoxazole-based antimicrobial agents and evaluation of their cytotoxicity and acute toxicity. Kondrashov EV; Belovezhets LA; Shatokhina NS; Shilova AN; Kostyro YA; Markova YA; Borovskaya MK; Borovskii GB Bioorg Chem; 2023 Sep; 138():106644. PubMed ID: 37302315 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of simplified analogues of MraY inhibitory natural product with rigid scaffold. Okamoto K; Ishikawa A; Okawa R; Yamamoto K; Sato T; Yokota SI; Chiba K; Ichikawa S Bioorg Med Chem; 2022 Feb; 55():116556. PubMed ID: 35016115 [TBL] [Abstract][Full Text] [Related]
7. Stable peri-Naphthoisatogens without C2 Protection: Synthesis via Aldrone Condensation, Optical Properties and 1,3-Dipolar Cycloaddition Reaction. Debnath I; Roy T; Borah D; Mahata K Chem Asian J; 2023 Dec; 18(24):e202300827. PubMed ID: 37929899 [TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Evaluation of Novel 2-Methoxyestradiol Derivatives as Apoptotic Inducers Through an Intrinsic Apoptosis Pathway. Sheng LX; Zhang JY; Li L; Xie X; Wen XA; Cheng KG Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936880 [TBL] [Abstract][Full Text] [Related]
9. Metabolic Characterization of Supernatants Produced by Fuochi V; Coniglio MA; Laghi L; Rescifina A; Caruso M; Stivala A; Furneri PM Front Microbiol; 2019; 10():1403. PubMed ID: 31293545 [No Abstract] [Full Text] [Related]
10. Capturing Biological Activity in Natural Product Fragments by Chemical Synthesis. Crane EA; Gademann K Angew Chem Int Ed Engl; 2016 Mar; 55(12):3882-902. PubMed ID: 26833854 [TBL] [Abstract][Full Text] [Related]
11. Chemistry and structure-activity relationship of antibacterial nucleoside natural products. Ichikawa S; Matsuda A Nucleic Acids Symp Ser (Oxf); 2008; (52):77-8. PubMed ID: 18776261 [TBL] [Abstract][Full Text] [Related]
12. Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY. Patel B; Ryan P; Makwana V; Zunk M; Rudrawar S; Grant G Eur J Med Chem; 2019 Jun; 171():462-474. PubMed ID: 30933853 [TBL] [Abstract][Full Text] [Related]
13. Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry. Berthet M; Cheviet T; Dujardin G; Parrot I; Martinez J Chem Rev; 2016 Dec; 116(24):15235-15283. PubMed ID: 27981833 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of isoxazolidine-containing uridine derivatives as caprazamycin analogues. Yamaguchi M; Matsuda A; Ichikawa S Org Biomol Chem; 2015 Jan; 13(4):1187-97. PubMed ID: 25428330 [TBL] [Abstract][Full Text] [Related]
15. Function-oriented synthesis of simplified caprazamycins: discovery of oxazolidine-containing uridine derivatives as antibacterial agents against drug-resistant bacteria. Ii K; Ichikawa S; Al-Dabbagh B; Bouhss A; Matsuda A J Med Chem; 2010 May; 53(9):3793-813. PubMed ID: 20405928 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of caprazamycin analogues and their structure--activity relationship for antibacterial activity. Hirano S; Ichikawa S; Matsuda A J Org Chem; 2008 Jan; 73(2):569-77. PubMed ID: 18092805 [TBL] [Abstract][Full Text] [Related]